Earnings Highlights: LEN.B, LEN, KEP, FPS, TCOM, KR, Projections - See Details Inside! ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­
Earnings360 Home
What's the Best Way to Lower RMD Taxes? (ad)
What's the Best Way to Lower RMD Taxes?
Once you turn 73, the IRS requires you to take distributions from your IRA, 401(k), and other retirement accounts - and without a plan, those required minimum distributions can carry a serious tax cost.

SmartAsset's model suggests working with a fiduciary financial advisor could potentially add 36% to 212% more dollar value to a portfolio over a lifetime. Their no-cost tool matches you with vetted advisors in your area who are legally bound to act in your interest.
 
Find and compare fiduciary financial advisors serving your area todaytc pixel
Top Earnings News
Coach’s Momentum Powers Tapestry Despite the Stock’s Sharp Pullback
Insiders Signal Deep Value In DICK’s Sporting Goods
A “bloodbath” Is Comingtc pixel 
5 Dividend Stocks That Combine Income, Earnings Growth, and Wall Street Support
These 3 AI Stocks Sold Off Hard—Even as Their Outlooks Improved
From Hyperscalers to High-Yield, These 3 Indsutry Giants Are Boosting Dividends
3 Software Stocks Rebounding as AI Fears Give Way to Growth
He called Apple then saw 12,000%+ gains. Now he's pointing at THIS.tc pixel 
Gold Has Gone Sideways, But These 3 Stocks Haven’t
These 3 Stocks Under $20 Have Wall Street Looking Past the Share Price
Lennar’s Earnings Miss May Be Sending a Bigger Warning About U.S. Housing
These 3 Agentic AI Stocks Have More Than Hype Behind Their Growth Stories

Monday, September 21 Today's Earnings Announcements

CompanyCurrent PriceConsensus EPSActual EPSBeat/MissConsensus RevenueActual RevenueYoY Revenue GrowthReport
ANAB AnaptysBio$54.99($0.47)$5.11$5.58$27.49$14.06
Moderna Doubled in One Day. This Medical Stock Could Be Next (ad)
Moderna Doubled in One Day. This Medical Stock Could Be Next
Moderna's stock doubled in a single day after its cancer vaccine hit key Phase 3 goals, and Merck jumped too. But according to a former Steve Cohen fund manager, the next big opportunity is not Moderna or Merck.

It is a different kind of company tied to a technology already backed by Elon Musk, Sam Altman, Jeff Bezos, and Peter Thiel. Nvidia's Jensen Huang says it will have a dramatic impact on daily life, while Anthropic's CEO believes it could unlock a century of medical progress in just ten years.

Nature Magazine estimates its potential value at $367 trillion globally, and it is already rolling out across the United States.
 
Click here to learn about this new era of medical technologytc pixel

Upcoming Earnings Reports

CompanyRelease DateRelease Time
WIMI WiMi Hologram Cloud9/24/2026Morning

MarketBeat Earnings Tools